E Kr̆epela
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Papers in
- Oncology 35
- Peptidase Inhibition and Analysis 28
-
- Cell death mechanisms and regulation 6
- Signaling Pathways in Disease 4
- Co-authors
- Aleksi Šedo (18 shared papers)Pavel Fiala (6 shared papers)Petr Zatloukal (4 shared papers)A Kubík (3 shared papers)Jurij Rozhin (2 shared papers)Bonnie F. Sloane (2 shared papers)Kamiar Moin (1 shared paper)Luboš Petruželka (2 shared papers)
In The Last Decade
E Kr̆epela
47 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 360
- Oncology 631
- Immunology and Allergy 68
- Pulmonary and Respiratory Medicine 354
- Cellular and Molecular Neuroscience 171
Countries citing papers authored by E Kr̆epela
This map shows the geographic impact of E Kr̆epela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kr̆epela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kr̆epela more than expected).
Fields of papers citing papers by E Kr̆epela
This network shows the impact of papers produced by E Kr̆epela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kr̆epela. The network helps show where E Kr̆epela may publish in the future.
Co-authors
The 25 scholars most cited alongside E Kr̆epela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 347 | |
| 2 | 1990 | 175 | |
| 3 | 2009 | 83 | |
| 4 | 2016 | 68 | |
| 5 | 2007 | 68 | |
| 6 | 2004 | 56 | |
| 7 | 2004 | 52 | |
| 8 | 2004 | 49 | |
| 9 | Cysteine proteinases in tumor cell growth and apoptosis. | 2001 | 49 |
| 10 | Increased cathepsin B activity in human lung tumors. | 1990 | 45 |
| 11 | 1987 | 36 | |
| 12 | 2012 | 34 | |
| 13 | 1991 | 34 | |
| 14 | Cathepsin B in human breast tumor tissue and cancer cells. | 1989 | 26 |
| 15 | 2017 | 24 | |
| 16 | Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. | 1998 | 24 |
| 17 | 2012 | 22 | |
| 18 | 2005 | 21 | |
| 19 | The malignant phenotype and cysteine proteinases. | 1991 | 21 |
| 20 | 2008 | 20 |
About E Kr̆epela
E Kr̆epela is a scholar working on Oncology, Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience and Epidemiology, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (28 papers), Protease and Inhibitor Mechanisms (16 papers), Neuropeptides and Animal Physiology (9 papers), Cell death mechanisms and regulation (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Bone and Dental Protein Studies (5 papers), Diabetes Treatment and Management (4 papers) and Signaling Pathways in Disease (4 papers). The work is most often cited by research in Cancer Research (360 citations), Oncology (631 citations), Immunology and Allergy (68 citations), Pulmonary and Respiratory Medicine (354 citations) and Cellular and Molecular Neuroscience (171 citations). E Kr̆epela has collaborated with scholars based in Czechia, India and Russia. Frequent co-authors include Aleksi Šedo, Pavel Fiala, Petr Zatloukal, A Kubík, Jurij Rozhin, Bonnie F. Sloane, Kamiar Moin, Luboš Petruželka, E Kasafírek and Libor Havel. Their work appears in journals such as Biological Chemistry, Lung Cancer, International Journal of Oncology, Journal of Cancer Research and Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.